Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy.
The study investigates why small cell lung cancer (SCLC) is initially chemosensitive yet prone to relapse, and identifie...
The study investigates why small cell lung cancer (SCLC) is initially chemosensitive yet prone to relapse, and identifie...
Phase II single‑arm trial of frontline BCMA CAR‑T in transplant‑ineligible NDMM Design: - Population: Newly diagn...
Study question Can tumor metabolic subtypes predict which patients with locoregionally advanced nasopharyngeal carcino...
This publication is an updated clinical practice guideline from ASCO on communication in cancer care. It was developed...
This review article focuses on advanced-stage non-small-cell lung cancer (NSCLC) in the era of immunotherapy and emphasi...
This population-based study used Japan’s National Cancer Registry (2016–2020) to examine how the route of detection...